News

The trial involves around 132 healthy subjects with head lice infestation, 2 years of age and older, in two study centers in the US. DeOvo, a topical formulation

Magellan’s Medical Pharmacy Solutions program is operated by its specialty pharmaceutical division, Icore Healthcare. The accreditation provides assurance to patients, providers, purchasers, regulators and employers that the practices

TMC435, an investigational CHC protease inhibitor currently in phase 3 clinical development, is a highly potent, selective and safe once-daily (q.d.) drug jointly developed by Tibotec Pharmaceuticals to

Perampanel is an orally administered, highly selective non-competitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptor antagonist discovered and being developed by Eisai. In Study 305, the response rates (defined as

The company is developing an antigen found in most human cancers. Sirona CEO Howard Verrico said vaccines using these antigens have the potential to treat and prevent many

Anatabloc, which contains dietary ingredient anatabine citrate, is developed by Rock Creek Pharmaceuticals, a subsidiary of Star Scientific. The company has submitted a provisional patent application with the

episil is a patented oral spray indicated for local treatment of pain related to oral mucositis. The tie up allows Teva to commercialize episil in Germany, Spain, Poland,

Following the acquisition, Monistat will continue to be available through existing retail channels and will be marketed under Insight Pharmaceuticals growing portfolio of products. Insight Pharma CEO Gary

Relistor Subcutaneous Injection is indicated for the treatment for opioid-induced constipation (OIC) in patients with non-cancer pain. Salix Research and Development executive vice president and chief development officer